» Articles » PMID: 29425851

Mechanistic Aspects of Epigenetic Dysregulation in SLE

Overview
Journal Clin Immunol
Date 2018 Feb 10
PMID 29425851
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic events have been linked with disease expression in individuals genetically predisposed to the development of systemic lupus erythematosus (SLE), a severe systemic autoimmune/inflammatory disease. Altered DNA methylation and hydroxymethylation as well as histone modifications mediate changes in chromatin accessibility and gene expression in immune cells from SLE patients. Defective epigenetic control contributes to uncontrolled expression of inflammatory mediators, including cytokines and co-receptors, resulting in systemic inflammation and tissue damage. While the pathophysiological involvement of epigenetic changes in SLE has been accepted for some time, we only recently started to investigate and understand molecular events contributing to epigenetic dysregulation. Here, epigenetic alterations will be discussed with a focus on underling molecular events that may be target of preventative measures or future treatment strategies.

Citing Articles

Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways.

Kaszycki J, Kim M Front Immunol. 2025; 16:1529756.

PMID: 40046056 PMC: 11879833. DOI: 10.3389/fimmu.2025.1529756.


Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus.

Charras A, Hiraki L, Lewandowski L, Hedrich C Curr Opin Rheumatol. 2024; 37(2):149-163.

PMID: 39660463 PMC: 11789615. DOI: 10.1097/BOR.0000000000001072.


Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity.

Gravand A, Alesaeidi S, Khoshbakht S, Saghaei M, Kenarangi T, Mosallaei M Clin Rheumatol. 2023; 42(12):3387-3395.

PMID: 37597101 DOI: 10.1007/s10067-023-06736-z.


Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE).

Natoli V, Charras A, Hahn G, Hedrich C Mol Cell Pediatr. 2023; 10(1):5.

PMID: 37556020 PMC: 10412509. DOI: 10.1186/s40348-023-00161-7.


Effects of Dietary Oleacein Treatment on Endothelial Dysfunction and Lupus Nephritis in Balb/C Pristane-Induced Mice.

Munoz-Garcia R, Sanchez-Hidalgo M, Alcarranza M, Vazquez-Roman M, de Sotomayor M, Gonzalez-Rodriguez M Antioxidants (Basel). 2023; 12(6).

PMID: 37372034 PMC: 10294986. DOI: 10.3390/antiox12061303.